Skip to main content

Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI.

Publication ,  Journal Article
Gwathmey, KG; Sadjadi, R; Horton, WB; Conaway, MR; Barnett-Tapia, C; Bril, V; Russell, JW; Shaibani, A; Mauermann, ML; Hehir, MK; Kolb, N ...
Published in: Neurology
June 5, 2018

OBJECTIVE: We studied the performance of a 15-item, health-related quality-of-life polyneuropathy scale in the clinic setting in patients with diabetic distal sensorimotor polyneuropathy (DSPN). METHODS: Patients with DSPN from 11 academic sites completed a total of 231 Chronic Acquired Polyneuropathy Patient-Reported Index (CAPPRI) scales during their clinic visits. Conventional and modern psychometric analyses were performed on the completed forms. RESULTS: Conventional and modern analyses generally indicated excellent psychometric properties of the CAPPRI in patients with DSPN. For example, the CAPPRI demonstrated unidimensionality and performed like an interval-level scale. CONCLUSION: Attributes of the CAPPRI for DSPN include ease of use and interpretation; unidimensionality, allowing scores to be summed; adequate coverage of disease severity; and the scale's ability to address relevant life domains. Furthermore, the CAPPRI is free and in the public domain. The CAPPRI may assist the clinician and patient with DSPN in estimating disease-specific quality of life, especially in terms of pain, sleep, psychological well-being, and everyday function. The CAPPRI may be most useful in the everyday clinical setting but merits further study in this setting, as well as the clinical trial setting.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neurology

DOI

EISSN

1526-632X

Publication Date

June 5, 2018

Volume

90

Issue

23

Start / End Page

e2034 / e2041

Location

United States

Related Subject Headings

  • United States
  • Severity of Illness Index
  • Retrospective Studies
  • Reproducibility of Results
  • Quality of Life
  • Psychometrics
  • Neurology & Neurosurgery
  • Middle Aged
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gwathmey, K. G., Sadjadi, R., Horton, W. B., Conaway, M. R., Barnett-Tapia, C., Bril, V., … Burns, T. M. (2018). Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI. Neurology, 90(23), e2034–e2041. https://doi.org/10.1212/WNL.0000000000005643
Gwathmey, Kelly G., Reza Sadjadi, William B. Horton, Mark R. Conaway, Carolina Barnett-Tapia, Vera Bril, James W. Russell, et al. “Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI.Neurology 90, no. 23 (June 5, 2018): e2034–41. https://doi.org/10.1212/WNL.0000000000005643.
Gwathmey KG, Sadjadi R, Horton WB, Conaway MR, Barnett-Tapia C, Bril V, et al. Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI. Neurology. 2018 Jun 5;90(23):e2034–41.
Gwathmey, Kelly G., et al. “Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI.Neurology, vol. 90, no. 23, June 2018, pp. e2034–41. Pubmed, doi:10.1212/WNL.0000000000005643.
Gwathmey KG, Sadjadi R, Horton WB, Conaway MR, Barnett-Tapia C, Bril V, Russell JW, Shaibani A, Mauermann ML, Hehir MK, Kolb N, Guptill J, Hobson-Webb L, Gable K, Raja S, Silvestri N, Wolfe GI, Smith AG, Malik R, Traub R, Joshi A, Elliott MP, Jones S, Burns TM. Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI. Neurology. 2018 Jun 5;90(23):e2034–e2041.

Published In

Neurology

DOI

EISSN

1526-632X

Publication Date

June 5, 2018

Volume

90

Issue

23

Start / End Page

e2034 / e2041

Location

United States

Related Subject Headings

  • United States
  • Severity of Illness Index
  • Retrospective Studies
  • Reproducibility of Results
  • Quality of Life
  • Psychometrics
  • Neurology & Neurosurgery
  • Middle Aged
  • Male
  • Humans